ISRG Stock Recent News
ISRG LATEST HEADLINES
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
SUNNYVALE, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the first in a series of new software capabilities for da Vinci 5, designed to enhance surgeon and hospital efficiency through the delivery of a range of real-time surgical insights.
If you don't know much about Intuitive Surgical (ISRG 1.68%), you might want to remedy that. It's a very impressive growth stock.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Intuitive Surgical, Inc. (ISRG) closed at $449.98 in the latest trading session, marking a -3.76% move from the prior day.
Intuitive Surgical's Ion platform is driving rapid growth, but cost optimization could be the key to turning it from a margin drag to a margin lever.
Next-generation technology enhances precision, improves patient outcomes, and expands minimally invasive surgery across Long Beach, Fountain Valley and Laguna Hills. FOUNTAIN VALLEY, Calif.
Intuitive Surgical (ISRG 3.04%) fell about 6% on Wednesday, following remarks at a healthcare conference, where management flagged tariff and international-market pressures.
Intuitive Surgical stock (NASDAQ: ISRG) has dropped 16% this year, notably lagging behind the S&P 500's 10% increase. The stock has experienced downward pressure recently after management indicated that potential tariffs may adversely affect its performance in 2026.
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 9:30 AM EDT Company Participants David Rosa - CEO & Director Jamie Samath - CFO, Head of Business Technology & Enterprise Technology Leader Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst All right. Good morning, everyone.